<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02933060</url>
  </required_header>
  <id_info>
    <org_study_id>16-133</org_study_id>
    <nct_id>NCT02933060</nct_id>
  </id_info>
  <brief_title>Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache</brief_title>
  <official_title>Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache: a Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cooper Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cooper Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether patients in the emergency department with
      migraine headache who are administered an intravenous fluid bolus will report greater
      improvement in pain scores than control patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators intend to perform a small-scale pilot study assessing the effectiveness of
      IV fluid therapy for patients presenting to the ED with migraine headache. Patients will be
      randomly allocated to receive a bolus of 1000 ml normal saline or no fluid bolus. Patients
      and outcome assessors will be blinded to the assigned study group. Research assistants will
      assess pain scores, nausea, and functional disability at time 0 (just prior to starting the
      intervention), 60 minutes, and 120 minutes. Participants will be contacted 48 hours after
      leaving the ED to assess symptom burden following discharge.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Actual">September 28, 2017</completion_date>
  <primary_completion_date type="Actual">September 26, 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Verbal Pain Score at 60 Minutes</measure>
    <time_frame>60 minutes</time_frame>
    <description>The primary outcome will be the difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and one hour later, at completion of the intervention. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Verbal Pain Score at 120 Minutes</measure>
    <time_frame>120 minutes</time_frame>
    <description>The difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and 2 hours later. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Free of Pain at 2 Hours</measure>
    <time_frame>120 minutes</time_frame>
    <description>Percentage of patients in each group who are pain-free two hours after initiation of the study intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients With no or Mild Functional Disability Due to Headache at 60 Minutes</measure>
    <time_frame>60 minutes</time_frame>
    <description>Percentage of patients with functional disability due to headache rated as none or mild (able to perform all activities of daily living, but with some difficulty) at 60 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Who Would Want the Same IV Fluid Treatment on a Future Visit</measure>
    <time_frame>48 hours</time_frame>
    <description>Percentage of participants answering &quot;yes&quot; to the question: &quot;The next time you visit the ED with a headache, would you wish to receive the same IV fluid treatment again?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Who Needed Rescue Medications</measure>
    <time_frame>120 minutes</time_frame>
    <description>Need for additional medications for pain control as determined by the treating physician.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>1 day</time_frame>
    <description>Length of emergency department stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verbal Pain Score at 48 Hours</measure>
    <time_frame>48 hours</time_frame>
    <description>Current pain as reported by participants at 48 hour follow-up (0-10 verbal scale; 0 = No Pain, 10 = Maximum Pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Reporting no Nausea or Mild Nausea at 60 Minutes</measure>
    <time_frame>60 mins</time_frame>
    <description>Patients reporting no nausea or mild nausea</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Verbal Report of Insertion Site Pain Score at 60 Minutes</measure>
    <time_frame>60 minutes</time_frame>
    <description>Pain at IV insertion site (0 = No Pain, 10 = Maximum Pain)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Migraine Headache</condition>
  <arm_group>
    <arm_group_label>IV fluid bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal saline (1000 mL)</intervention_name>
    <arm_group_label>IV fluid bolus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Fluent in English

          -  Meets International Classification of Headache Disorders (3rd ed) criteria for
             migraine headache:

        A. At least five attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours
        (untreated or unsuccessfully treated)

        C. Headache has at least two of the following four characteristics:

        unilateral location pulsating quality moderate or severe pain intensity aggravation by or
        causing avoidance of routine physical activity (e.g. walking or climbing stairs)

        D. During headache at least one of the following:

          1. nausea and/or vomiting

          2. photophobia and phonophobia E. Not better accounted for by another ICHD-3 diagnosis.

        Exclusion Criteria:

          -  Intravenous Fluids are contraindicated in the opinion of the emergency department
             physician caring for the patient (ex patient has an exacerbation of congestive heart
             failure).

          -  Intravenous fluids are required in the opinion of the emergency department physician
             caring for the patient (ex patient has intractable vomiting, patient has severe
             dehydration).

          -  Have already received greater than or equal to 500 ml of intravenous fluid during this
             emergency department visit, prior to enrollment.

          -  Currently pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Jones, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cooper Medical School of Rowan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cooper Univeristy Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2016</study_first_posted>
  <results_first_submitted>October 17, 2018</results_first_submitted>
  <results_first_submitted_qc>February 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 3, 2019</results_first_posted>
  <last_update_submitted>July 3, 2019</last_update_submitted>
  <last_update_submitted_qc>July 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cooper Health System</investigator_affiliation>
    <investigator_full_name>Christopher Jones</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>intravenous fluid</keyword>
  <keyword>headache</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 8, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT02933060/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IV Fluid Bolus</title>
          <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Fluid Bolus</title>
          <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34" lower_limit="25" upper_limit="40"/>
                    <measurement group_id="B2" value="37" lower_limit="30" upper_limit="50"/>
                    <measurement group_id="B3" value="35" lower_limit="28" upper_limit="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Verbal Pain Score; median (IQR)</title>
          <description>(0 = no pain, 10 = maximum pain)</description>
          <units>Units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8" lower_limit="7" upper_limit="10"/>
                    <measurement group_id="B2" value="9" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="B3" value="9" lower_limit="7.5" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Verbal Pain Score at 60 Minutes</title>
        <description>The primary outcome will be the difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and one hour later, at completion of the intervention. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.</description>
        <time_frame>60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Score at 60 Minutes</title>
          <description>The primary outcome will be the difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and one hour later, at completion of the intervention. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.</description>
          <units>units on a scale (0-10)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="3.7" upper_limit="5.3"/>
                    <measurement group_id="O2" value="4.9" lower_limit="3.5" upper_limit="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Pain Score at 120 Minutes</title>
        <description>The difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and 2 hours later. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.</description>
        <time_frame>120 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Score at 120 Minutes</title>
          <description>The difference in verbal pain rating (0 = no pain, 10 = maximum pain) between the start of the study intervention and 2 hours later. The minimum clinically significant difference between treatment groups on the 0-10 verbal scale is 1.3.</description>
          <units>units on a scale (0-10)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" lower_limit="4.8" upper_limit="7.1"/>
                    <measurement group_id="O2" value="5.5" lower_limit="4.1" upper_limit="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Free of Pain at 2 Hours</title>
        <description>Percentage of patients in each group who are pain-free two hours after initiation of the study intervention.</description>
        <time_frame>120 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Free of Pain at 2 Hours</title>
          <description>Percentage of patients in each group who are pain-free two hours after initiation of the study intervention.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients With no or Mild Functional Disability Due to Headache at 60 Minutes</title>
        <description>Percentage of patients with functional disability due to headache rated as none or mild (able to perform all activities of daily living, but with some difficulty) at 60 minutes</description>
        <time_frame>60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With no or Mild Functional Disability Due to Headache at 60 Minutes</title>
          <description>Percentage of patients with functional disability due to headache rated as none or mild (able to perform all activities of daily living, but with some difficulty) at 60 minutes</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Who Would Want the Same IV Fluid Treatment on a Future Visit</title>
        <description>Percentage of participants answering &quot;yes&quot; to the question: &quot;The next time you visit the ED with a headache, would you wish to receive the same IV fluid treatment again?&quot;</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Who Would Want the Same IV Fluid Treatment on a Future Visit</title>
          <description>Percentage of participants answering &quot;yes&quot; to the question: &quot;The next time you visit the ED with a headache, would you wish to receive the same IV fluid treatment again?&quot;</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Who Needed Rescue Medications</title>
        <description>Need for additional medications for pain control as determined by the treating physician.</description>
        <time_frame>120 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Who Needed Rescue Medications</title>
          <description>Need for additional medications for pain control as determined by the treating physician.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay</title>
        <description>Length of emergency department stay</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>Length of emergency department stay</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="309" spread="68"/>
                    <measurement group_id="O2" value="316" spread="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Pain Score at 48 Hours</title>
        <description>Current pain as reported by participants at 48 hour follow-up (0-10 verbal scale; 0 = No Pain, 10 = Maximum Pain).</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Score at 48 Hours</title>
          <description>Current pain as reported by participants at 48 hour follow-up (0-10 verbal scale; 0 = No Pain, 10 = Maximum Pain).</description>
          <units>units on a scale (0-10)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="3.3"/>
                    <measurement group_id="O2" value="1.9" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Reporting no Nausea or Mild Nausea at 60 Minutes</title>
        <description>Patients reporting no nausea or mild nausea</description>
        <time_frame>60 mins</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Reporting no Nausea or Mild Nausea at 60 Minutes</title>
          <description>Patients reporting no nausea or mild nausea</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                    <measurement group_id="O2" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Verbal Report of Insertion Site Pain Score at 60 Minutes</title>
        <description>Pain at IV insertion site (0 = No Pain, 10 = Maximum Pain)</description>
        <time_frame>60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Fluid Bolus</title>
            <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Report of Insertion Site Pain Score at 60 Minutes</title>
          <description>Pain at IV insertion site (0 = No Pain, 10 = Maximum Pain)</description>
          <units>units on a scale (0-10)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="0.97"/>
                    <measurement group_id="O2" value="0.73" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>48 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>IV Fluid Bolus</title>
          <description>Patients will receive a 1000 ml bolus of normal saline, administered over 60 minutes.
Normal saline (1000 mL)</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patients will have an IV catheter and will be connected to an IV bag, but will receive only 10 ml of normal saline over 60 minutes.
Control</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was a small-scale pilot study. The wide confidence intervals we observed do not exclude the possibility of a clinically relevant treatment effect.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Christopher Jones</name_or_title>
      <organization>Cooper University Health System</organization>
      <phone>856-342-2627</phone>
      <email>jones-christopher@cooperhealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

